Literature DB >> 2105117

Stimulating reporting of adverse drug reactions by using a fee.

J Feely1, S Moriarty, P O'Connor.   

Abstract

Mesh：

Year:  1990        PMID： 2105117      PMCID： PMC1661889          DOI： 10.1136/bmj.300.6716.22

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Spontaneous reporting of adverse drug reactions. I: the data.

Authors:  M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

2.  Review of yellow cards--1986 and 1987.

Authors:  J L Bem; R D Mann; M D Rawlins
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-07
  2 in total
  27 in total

1.  Underreporting of adverse drug reactions: attitudes of Irish doctors.

Authors:  D Williams; J Feely
Journal:  Ir J Med Sci       Date:  1999 Oct-Dec       Impact factor: 1.568

2.  Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription pads.

Authors:  Josep Maria Castel; Albert Figueras; Consuelo Pedrós; Joan-Ramon Laporte; Dolors Capellà
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  The influence of pharmacoeconomic factors on prescribing patterns in Ireland.

Authors:  J Feely
Journal:  Pharmacoeconomics       Date:  1992-08       Impact factor: 4.981

4.  A distance-learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via the UK yellow card scheme.

Authors:  Robert C G Bracchi; Jane Houghton; Fiona J Woods; Simon Thomas; Simon A Smail; Philip A Routledge
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

5.  A small economic inducement to stimulate increased reporting of adverse drug reactions--a way of dealing with an old problem?

Authors:  M Bäckström; T Mjörndal
Journal:  Eur J Clin Pharmacol       Date:  2006-03-30       Impact factor: 2.953

6.  Is there still a role for spontaneous reporting of adverse drug reactions?

Authors:  Joel Lexchin
Journal:  CMAJ       Date:  2006-01-17       Impact factor: 8.262

Review 7.  Determinants of under-reporting of adverse drug reactions: a systematic review.

Authors:  Elena Lopez-Gonzalez; Maria T Herdeiro; Adolfo Figueiras
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

8.  An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain.

Authors:  Consuelo Pedrós; Antoni Vallano; Gloria Cereza; Gemma Mendoza-Aran; Antònia Agustí; Cristina Aguilera; Immaculada Danés; Xavier Vidal; Josep M Arnau
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

9.  Effectiveness of pharmacovigilance training of general practitioners: a retrospective cohort study in the Netherlands comparing two methods.

Authors:  Roald Gerritsen; Hans Faddegon; Fred Dijkers; Kees van Grootheest; Eugène van Puijenbroek
Journal:  Drug Saf       Date:  2011-09-01       Impact factor: 5.606

10.  Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria.

Authors:  Kazeem A Oshikoya; Jacob O Awobusuyi
Journal:  BMC Clin Pharmacol       Date:  2009-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.